phleomycins has been researched along with Carcinoma 256, Walker in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
TANAKA, N | 1 |
Allen, TE; Brown, DJ; Cowden, WB; Grigg, GW; Hart, NK; Lamberton, JA; Lane, A | 1 |
Aliano, NA; Allen, TE; Cowan, RJ; Grigg, GW; Hart, NK; Lamberton, JA; Lane, A | 1 |
3 other study(ies) available for phleomycins and Carcinoma 256, Walker
Article | Year |
---|---|
EFFECT OF PHLEOMYCIN ON DNA POLYMERASE OF TUMOR ORIGIN.
Topics: Anti-Bacterial Agents; Antineoplastic Agents; Carcinoma 256, Walker; DNA-Directed DNA Polymerase; Mitomycin; Mitomycins; Neoplasms; Nucleotidyltransferases; Pharmacology; Phleomycins; Research | 1965 |
Amplification of the antitumor activity of phleomycins in rats and mice by heterocyclic analogues of purines.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; Male; Mice; Phleomycins; Purines; Rats; Rats, Inbred Strains; Structure-Activity Relationship | 1984 |
Amplification of the antitumor activity of phleomycins and bleomycins in rats and mice by caffeine.
Topics: Animals; Bleomycin; Caffeine; Carcinoma 256, Walker; Carcinoma, Ehrlich Tumor; DNA; DNA Repair; Drug Synergism; Male; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Phleomycins; Rats; Rats, Inbred Strains | 1985 |